Dr Gurfinkel is one of 10 researchers who were recognised as one of Western Australia’s brightest minds for his research in the neuroscience field. In addition, Dr Jessica Cale and Dr Jun Yuan, from the Murdoch University affiliated Perron Institute, received the Early Mid Career Researcher Aspire Award from Business Events Perth. 

Dr Gurfinkel said this award has been a key part of his research career and has provided an opportunity to connect with other experts.  

“I’m honoured to receive the Murdoch University Aspire Award, which marks a significant milestone in my career,” Dr Gurfinkel said.  

My research focuses on developing personalised genetics therapies for people diagnosed with motor neurone disease, sometimes referred to as MND or ALS.  

Dr Yuval Gurfinkel

“MND is a fatal neurodegenerative disease that results in the breakdown of motor neurones - the connections between the brain and the muscle, which can result in paralysis and death of people with MND.” 

Throughout his career, Dr Gurfinkel has focused on MND genetic therapy, resulting in numerous co-authored publications.  

Following his PhD completion at the University of Western Australia, Dr Gurfinkel is now a postdoctoral research associate at the Personalised Medicine Centre based at Murdoch University, where he is collaborating with colleagues from the Perron Institute and King’s College London. 

There is currently no cure of MND, and there are around 2000 people living with MND in Australia today, with 2 people diagnosed with MND every day in and tragically also 2 people who pass as a result of MND.

Dr Yuval Gurfinkel

“WA has a larger amount of people living with MND per capita in comparison to other states in Australia. So, addressing this local challenge is vital, and I believe our region is leading the way in innovative solutions.” 

Deputy Vice Chancellor of Research and Innovation at Murdoch University Professor Peter Eastwood explained how Dr Gurfinkel’s research is changing lives and supporting those with MND in WA. 

Dr Yuval Gurfinkel, whose work in genetic therapeutics for motor neuron disease, has strengthened our capabilities and supports Murdoch University’s shared purpose; which is to change lives and society for the better through accessible research and education.

Deputy Vice Chancellor Research and Innovation, Professor Peter Eastwood

“His dedication and insight have helped position Murdoch University as an impactful leader in MND research and support those living with MND in Western Australia.” 

Gareth Martin, CEO, Business Events Perth congratulated the 2025 Aspire Award recipients for their outstanding achievements. 

“Each year, the Aspire Awards showcase the incredible depth of talent, innovation and leadership within Western Australia’s academic and professional community. These recipients exemplify the spirit of curiosity, collaboration and achievement that drives our State’s reputation for excellence on the global stage,” he said. 

As the 2025 Aspire Award winner, Dr Gurfinkel will be attending the 37th International Symposium on ALS/MND, a self-nominated trip funded by Business Events Perth.  

“What I love most about my work is collaborating with talented individuals and pursuing the essential work that is required to develop therapies for people who need it most,” Dr Gurfinkel said. 

“I’ll be attending the International Symposium on MND/ALS, where I’ll have opportunities to connect with industry leaders, working together to plan collaborative studies to advance the therapies being developed for MND.” 

Winning the Aspire Award isn’t just an honour for me; it’s a recognition of the collective effort of everyone involved in this journey. It motivates me to keep pushing boundaries and aiming for excellence.

Dr Yuval Gurfinkel